Latest filing published 03 Sept 2026 for Pulmonx Corp, €7,408.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by David Aaron Lehman span 2 companies, the busiest being Pulmonx Corp and Intersect ENT, Inc. Over a trading history stretching from 18 January 2017 to 1 September 2026, the count stands at 85 filings.
On the market, this insider has only sold: 64 sales, €2.1M in total. Besides market trades, the filings include 18 share grants and 3 option exercises. Since January 2026: no purchases and 8 sales on the market.
The newest entry dates from 3 September 2026: an open-market sale of €7,408, in Pulmonx Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations